Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist pharmaceutical and biotech companies protect their most valuable assets and position them for future success. Our extensive experience, technical expertise, big picture vision and integrated strategy consistently produce favorable outcomes for companies developing, protecting, and commercializing drugs and therapies. Our attorneys share decades of experience in partnering with both generic and brand companies, assisting them in navigating the most complex IP issues, including the Hatch-Waxman Act.

We focus on helping clients build effective IP strategies that secure market position, or overcome obstacles to new product entry--whether this requires litigation or pre-litigation planning (505(b)(2), ANDA), Inter Partes Reviews, assessment of FDA exclusivity issues, opinions or portfolio analysis/development. Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.